Short- and long-term responses to molybdenum-99 shortages in nuclear medicine

British Journal of Radiology

Volumn 83, Issue 995, 2010, Pages 899-901

  Ballinger, J R ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; MOLYBDENUM 99; RUBIDIUM 82;

COMPUTER ASSISTED TOMOGRAPHY; MYOCARDIAL PERFUSION IMAGING; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; REACTOR; TECHNOLOGY;

HALF-LIFE; HEALTH SERVICES ACCESSIBILITY; HUMANS; LOBBYING; MOLYBDENUM; NUCLEAR MEDICINE; NUCLEAR REACTORS; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVITY; RADIOISOTOPES; RADIONUCLIDE GENERATORS;

EID: 78049342773     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/17139152     Document Type: Note

References (6)

1. Sondheim S, Goldman J. Follies: a musical. New York, Random House: 1971.
2. National Academy of Sciences (USA). Medical isotope production without highly enriched uranium. Washington, USA, National Academies Press 2009.
3. Anonymous. Current use and future needs of radiopharmaceuticals labelled with radionuclides produced in reactors and possible alternatives. Document EMA/150127/2010. 2010, European Medicines Agency, London.
4. Wivell G, editor. Cardiac imaging: a report of the National Imaging Board. March 2010 UK. Department of Health, Gateway reference number 13859.
5. 99Mo. Eur J Nucl Med 2010;37;1817-20.
6. m: an approach to the medical isotope crisis. J Nucl Med 2010;51:13N-16N.